Imho, I don't see bp even wanting half the pie for any reason other than ears on the inside & influence. Having said that, I don't see company doing big deals before s/c interim results unless for the whole pie. Also see bp waiting 'til last possible minute, to have a better handle on where covid is going. Glad we are going forward based on the known-we have a great product & could get it done solo. But I think after s/c results bp will come calling in a big way. If covid hangs around, I feel like sp could escalate to the same level now as 3 yrs from now. Therefore considering the risks that come with factors not associated with the science, imho NP will make the deal for a buyout.